Cigniti Tech. (CIGNITITEC)
Fast GrowerFairStock Score: 72/100 — STEADY
Score breakdown: P/E: 3/3 · ROCE: 2/2 · Growth: 2/2 · Dividend: 0/1
Key Financials
| Current Price | ₹1,260.1 |
| Market Cap | ₹3,237.59 Cr |
| P/E Ratio | 11.53 |
| ROCE | 34.09% |
| ROE | 36.71% |
| Dividend Yield | 0% |
| Profit Growth | 22.64% |
| Debt/Equity | 0.02 |
| Sales Growth | 47.74% |
| Promoter Holding | 54% |
| 52-Week Range | ₹996.5 — ₹1,929.5 |
| Sector | IT - Services |
| Book Value | ₹409.66 |
Strengths
- Excellent capital returns: ROE 36.71% and ROCE 34.09%
- Very low leverage: debt/equity of 0.02 and Piotroski F-Score of 7/9
- Valuation looks attractive on growth: P/E 10.60 against profit growth 31.76%, PEG 0.48
- Promoter holding of 54% aligns owner interest with minority shareholders
Concerns
- No dividend yield; total return depends entirely on capital gains
- P/B of 6.01 is high, leaving little asset-based margin of safety
- Profit growth of 31.76% far exceeds sales growth of 12.20%, so margin expansion must prove sustainable
- Price is roughly 38% below the 52-week high of ₹1929.50, with a wide trading range
AI Analysis
Let me start with the numbers I trust. Cigniti Tech has a ROE of 36.71%, ROCE of 34.09%, and debt/equity of just 0.02. That is a high-return, nearly debt-free business. Piotroski F-Score of 7 out of 9 also tells me the financial health is sound. As Graham said, buy a business as though it were a business; these ratios make me listen. The moat is not obvious from a single page. For an IT-enabled services firm, customer relationships, delivery capabilities, and scale create some protection. But I cannot see true pricing power when sales grew 12.20% and profit grew 31.76%. Most of the profit jump came from margin expansion, not a stronger top line. That is pleasant, but margins can normalize. If the business can grow profits around 30% for a few years, the P/E of 10.60 gives a PEG of 0.48. That would be a bargain. If profit growth slows to match sales growth, the low P/E is less exciting. Book value is ₹199.20 while price is ₹1197.90, so P/B is 6.01. I am paying a large premium to asset value; I will only do that for a wide-moat compounder. There is no dividend here, so my entire return must come from the business reinvesting and growing. Promoter holding at 54% is a positive, though the stock sits 38% below its 52-week high of ₹1929.50. I need to know why the market turned cold. Latest quarter sales of ₹579 Cr and net profit of ₹80 Cr imply a net margin around 13.8%, decent. With FairStock Score of 63, it is steady, not spectacular. In summary, Cigniti has excellent capital metrics and reasonable valuation; my category is Fast Grower, but I would not buy without understanding the profit-versus-sales growth gap and the fall from the high.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer